ADAPTIVE BIOTECHNOLOGIES CORPORATION Increase (Decrease) in Other Operating Assets and Liabilities, Net
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $201.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was $103.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $98.00K, a 1533.33% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$137.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was $0.00.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was -$142.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$27.00K, a 136.99% decline from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was $73.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$169.00K, a 161.45% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $201.00K 10-Q · filed 2026-08-04 | $64.00K derived: sum of 3 quarters · filed 2026-08-04 | $64.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $98.00K 10-Q · filed 2026-05-05 | -$39.00K derived: sum of 2 quarters · filed 2026-05-05 | -$39.00K derived: sum of 3 quarters · filed 2026-05-05 | -$50.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$137.00K derived: sum of 2 quarters · filed 2026-02-26 | -$148.00K derived: sum of 3 quarters · filed 2026-08-04 | -$142.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$11.00K derived: sum of 2 quarters · filed 2026-08-04 | -$5.00K 10-Q · filed 2025-11-05 | -$10.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$5.00K 10-Q · filed 2026-08-04 | -$10.00K derived: sum of 3 quarters · filed 2026-08-04 | -$13.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $6.00K 10-Q · filed 2026-05-05 | $1.00K derived: sum of 2 quarters · filed 2026-05-05 | -$2.00K derived: sum of 3 quarters · filed 2026-05-05 | -$23.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.00K derived: sum of 2 quarters · filed 2026-02-26 | -$29.00K derived: sum of 3 quarters · filed 2026-02-26 | -$27.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$24.00K derived: sum of 2 quarters · filed 2025-11-05 | -$22.00K 10-Q · filed 2025-11-05 | -$25.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$19.00K 10-Q · filed 2025-08-05 | -$22.00K derived: sum of 3 quarters · filed 2026-02-26 | $42.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-01 | -$1.00K derived: sum of 2 quarters · filed 2026-02-26 | $63.00K derived: sum of 3 quarters · filed 2026-02-26 | $61.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $61.00K derived: sum of 2 quarters · filed 2026-02-26 | $59.00K derived: sum of 3 quarters · filed 2026-02-26 | $73.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $62.00K derived: sum of 2 quarters · filed 2024-11-07 | $76.00K 10-Q · filed 2024-11-07 | $72.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $12.00K 10-Q · filed 2024-08-01 | $8.00K derived: sum of 3 quarters · filed 2025-03-03 | -$60.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-07 | $10.00K derived: sum of 2 quarters · filed 2025-03-03 | -$58.00K derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$72.00K derived: sum of 2 quarters · filed 2025-03-03 | -$169.00K 10-K · filed 2025-03-03 | |
| 2022-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$165.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$97.00K 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $155.00K derived: sum of 2 quarters · filed 2024-02-29 | $156.00K derived: sum of 3 quarters · filed 2024-02-29 | $275.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $153.00K derived: sum of 2 quarters · filed 2022-11-03 | $272.00K 10-Q · filed 2022-11-03 | $333.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $120.00K 10-Q · filed 2022-08-03 | $181.00K derived: sum of 3 quarters · filed 2023-02-14 | $181.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $119.00K 10-Q · filed 2022-05-04 | $180.00K derived: sum of 2 quarters · filed 2023-02-14 | $180.00K derived: sum of 3 quarters · filed 2023-02-14 | $180.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $61.00K derived: sum of 2 quarters · filed 2023-02-14 | $61.00K derived: sum of 3 quarters · filed 2023-02-14 | $276.00K 10-K · filed 2023-02-14 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $215.00K 10-Q · filed 2021-11-03 | $275.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $215.00K 10-Q · filed 2021-08-04 | $275.00K derived: sum of 3 quarters · filed 2022-02-15 | $813.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $215.00K 10-Q · filed 2021-05-05 | $275.00K derived: sum of 2 quarters · filed 2022-02-15 | $813.00K derived: sum of 3 quarters · filed 2022-02-15 | |
| 2019-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $598.00K derived: sum of 2 quarters · filed 2022-02-15 | $597.00K 10-K · filed 2022-02-15 | |
| 2019-09-30 | $538.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $537.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | -$1.00K 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$25.00K derived: sum of 2 quarters · filed 2021-02-24 | $182.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $206.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $207.00K 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | -$24.00K 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |